Researchers at Simon Fraser University (SFU) are using a new brain imaging method that could help doctors better understand ...

Parkinson's Disease Therapeutics Market The Parkinson's therapeutics market will grow from USD 5.92 Bn in 2024 to USD 12.83 Bn by 2033 at 8 ...

A novel biodegradable gel delivers Parkinson's medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. | Drug Discovery And Development ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment ...

Detecting early rising Parkinson's disease (PD) symptoms could improve treatment outcomes by enabling earlier treatment interventions. In a new eNeuro ...

The levodopa challenge test is noninvasive, cost-effective, and easy to administer; tablets of carbidopa–levodopa are taken orally and motor symptoms are scored using the Unified Parkinson's ...

People with Parkinson’s disease may soon be able to manage their symptoms with a simple weekly injection instead of taking ...

About 90,000 people are diagnosed with Parkinson's disease (PD) each year—one person every six minutes. While most people ...

For the first two years of his life, little Hamdan Khaled Saleh Salmen lived in silence and stillness. Born prematurely at 34 ...

Anisotropic metal nanostructures with unique physicochemical properties are undeniable promising systems toward diverse applications, ranging from those in materials science to biological fields.

UniSA's weekly injectable gel delivers levodopa and carbidopa, potentially transforming Parkinson's care for 8.5M people by simplifying treatment and reducing side effects.